Discontinued — last reported Q1 '23

Operating

Expensed In Process Research And Development

Natera, Inc. Expensed In Process Research And Development increased by 15.3% to $2.68M in Q1 2023 compared to the prior quarter. Year-over-year, this metric grew by 15.3%, from $2.32M to $2.68M.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2023May 10, 2024

How to read this metric

High spending indicates aggressive investment in future product pipelines, though it suppresses current earnings.

Detailed definition

This represents the costs associated with research and development projects acquired in a business combination that have...

Peer comparison

Common in biotech and pharmaceutical sectors where R&D pipelines are frequently bolstered by acquisitions.

Metric ID: operating_expensed_in_process_research_and_development

Historical Data

8 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23
Value$8.90M$8.90M$8.90M$2.32M$2.32M$2.32M$2.32M$2.68M
QoQ Change+0.0%+0.0%-73.9%+0.0%+0.0%+0.0%+15.3%
YoY Change-73.9%-73.9%-73.9%+15.3%
Range$2.32M$8.90M
CAGR-49.6%
Avg YoY Growth-51.6%
Median YoY Growth-73.9%
Current Streak4 quarters growth

Frequently Asked Questions

What is Natera, Inc.'s expensed in process research and development?
Natera, Inc. (NTRA) reported expensed in process research and development of $2.68M in Q1 2023.
How has Natera, Inc.'s expensed in process research and development changed year-over-year?
Natera, Inc.'s expensed in process research and development increased by 15.3% year-over-year, from $2.32M to $2.68M.
What does expensed in process research and development mean?
The cost of R&D projects acquired from other companies that are not yet complete.